STOCK TITAN

Vanguard (NYSE: BCPC) reports zero beneficial ownership after realignment

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group reports it beneficially owns 0 shares (0%) of Balchem Corp common stock. The filing amends prior Schedule 13G filings to reflect an internal realignment effective January 12, 2026, under which certain Vanguard subsidiaries will report holdings separately.

This amendment states Vanguard holds no voting or dispositive power over Balchem common stock and that no single outside person is known to hold more than 5% of the class on Vanguard's behalf. The filing is signed by Ashley Grim on 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings after internal realignment; no Balchem shares reported.

The amendment confirms 0 shares beneficially owned and 0% voting or dispositive power in Balchem Corp as of the filing. It attributes the change to an internal realignment on January 12, 2026 and indicates certain subsidiaries will report separately in reliance on SEC Release No. 34-39538.

Cash‑flow treatment is not stated. Subsequent filings by Vanguard subsidiaries may show holdings if positions are held under different reporting entities.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does The Vanguard Group report for BCPC ownership?

The Vanguard Group reports 0 shares beneficially owned in Balchem Corp (BCPC), representing 0% of the class. The filing states Vanguard has no voting or dispositive power over Balchem common stock.

Why does Vanguard show zero ownership in this Schedule 13G/A for BCPC?

Vanguard amended its filing due to an internal realignment on January 12, 2026. Under SEC Release No. 34-39538, certain subsidiaries now report holdings separately from The Vanguard Group, Inc.

Does this amendment indicate any single holder over 5% for BCPC on Vanguard's behalf?

The filing states no other person's interest reported by Vanguard exceeds 5% of the class. A list of underlying shareholders is not required for registered investment companies or certain benefit plans.

Who signed the Schedule 13G/A amendment for Vanguard on BCPC?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with the signature date of 03/26/2026.

Will Vanguard subsidiaries file separate reports for BCPC holdings?

Yes. The amendment states certain subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538 following the January 12, 2026 realignment.
Balchem Corp

NASDAQ:BCPC

View BCPC Stock Overview

BCPC Rankings

BCPC Latest News

BCPC Latest SEC Filings

BCPC Stock Data

5.33B
31.82M
Specialty Chemicals
Chemicals & Allied Products
Link
United States
MONTVALE